Is a complete TPEX/6733 research report available?

No complete published report is available for tpex/6733 (TPEX/6733) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TPEX/6733 (TPEX/6733)

Taipei Exchange: TPEX/6733 · TWD

NT$25.2

-0.40 (-1.6%)· Recorded snapshot

Market cap	3.4B
Revenue (ttm)	236.6M
Net income (ttm)	-67.8M
EPS (ttm)	-NT$0.54
Shares out	134.3M
Volume	79,420
Beta	0.08

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 236.6M
Net income (ttm): -67.8M
EPS (ttm): -NT$0.54
Market cap: 3.4B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TPEX/6733 indicators

Market & fundamental data

Available fields

185

Groups with data

Currency

TWD

Showing 185 of 185 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees Change	0%
Employees Change Percent	0
Enterprise value	TWD 2.5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Biotechnology
Industry PE Fwd	32.85
Isin	TW0006733009
Last refreshed	2026-09-12
Market cap	TWD 3.4B
Price	TWD 25.15
Price currency	TWD
Sector	Healthcare
Sector PE	87.76
Sector PE Fwd	27.81
Sic	2836
Symbol	tpex/6733
Website	https://www.biogend.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.01%
EV/Sales	10.76x
FCF yield	-1.49%
P/B ratio	3.13x
P/S ratio	14.28x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-38.83%
EBITDA Margin	-19.54%
Gross margin	70.66%
Gross Profit	TWD 167.2M
Gross Profit Growth	14.5%
Gross Profit Growth Q	9.79%
Gross Profit Growth3 Y	44.27%
Gross Profit Growth5 Y	144.2%
Net Income	TWD -67.8M
Net Income Growth Years	3%
Pretax Margin	-35.74%
Profit Margin	-28.67%
ROA	-5.83
Roa5y	-10.83
ROCE	-8.39
ROE	-8.17
Roe5y	-17.26
ROIC	-6.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-43.71%
Cagr3y	-10.8%
Cagr5y	1.52%
EPS Growth Quarters	5
EPS Growth Years	3
Revenue Growth	21.31x
Revenue Growth Q	12.85x
Revenue Growth Qo Q	8.27x
Revenue Growth Quarters	8x
Revenue Growth Years	5x
Revenue Growth3 Y	50.18x
Revenue Growth5 Y	134.36x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.24
Assets	TWD 1.1B
Cash	TWD 849.8M
Current Assets	TWD 970.6M
Current Liabilities	TWD 30.2M
Debt	TWD 4.8M
Debt Equity	TWD 0
Debt FCF	TWD -0.09
Equity	TWD 1.1B
Interest Coverage	-685.6
Liabilities	TWD 45.7M
Long Term Assets	TWD 154.8M
Long Term Liabilities	TWD 15.5M
Net Cash	TWD 845M
Net Cash By Market Cap	TWD 25.02
Net Cash Growth	48.78%
Net Debt Equity	TWD -0.78
Tangible Book Value	TWD 997.1M
Tangible Book Value Per Share	TWD 7.42
WACC	4.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	32.13
Inventory Turnover	3.16
Net Working Capital	TWD 94.3M
Quick ratio	31.12
Working Capital	TWD 940.3M
Working Capital Turnover	TWD 0.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.75%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-43.69%
200-day SMA	31.4
3Y total return	-29.03%
50-day SMA	25.89
50-day SMA vs 200-day SMA	50under200
5Y total return	7.86%
All Time High	64.2
All Time High Change	-60.83%
All Time High Date	2020-07-09
All Time Low	14.74
All Time Low Change	70.62%
All Time Low Date	2020-03-19
ATR	0.8
Beta	0.08
Beta1y	0.11
Beta2y	0.3
Ch YTD	-34.51
High	25.45
High52	49.15
High52 Date	2025-09-15
High52ch	-48.83%
Low	25.05
Low52	23.45
Low52 Date	2026-06-26
Low52ch	7.25%
Ma50ch	-2.85%
Price vs 200-day SMA	-19.9%
RSI	41.72
RSI Monthly	39.51
RSI Weekly	38.42
Sharpe ratio	-1.6x
Sharpe Ratio3y	-0.39x
Sharpe Ratio5y	0.07x
Sortino ratio	-2.13
Sortino Ratio3y	-0.42
Sortino Ratio5y	0.31
Total Return	-1.75%
Tr YTD	-34.3
Tr1m	-3.08%
Tr1w	-5.09%
Tr3m	-4.19%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	77,465,179%
Net Borrowing	-3,722,000
Shares Insiders	3.97%
Shares Institutions	2.37%
Shares Out	134,316,000
Shares Qo Q	6.96%
Shares Yo Y	1.75%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD -59.2M
Adjusted OCF	-56,231,000
Average Volume	89,574.3x
Bv Per Share	7.95
CAPEX	TWD -2.9M
Ch1m	-3.08
Ch1w	-5.09
Ch1y	-43.86
Ch3m	-4.19
Ch3y	-29.25
Ch5y	6.12
Ch6m	-30.81
Change	-1.57%
Change From Open	-1.18
Close	25.55
Days Gap	-0.39
Depreciation Amortization	45,649,000
Dollar Volume	1,997,413
Earnings Date	2026-11-09
EBIT	TWD -91.9M
EBITDA	TWD -46.2M
EPS	TWD -0.54
F Score	3
FCF	TWD -50.2M
FCF EV Yield	-1.97x
FCF Per Share	TWD -0.37
Financing CF	356,278,000
Fiscal Year End	December
Founded	2,016
Goodwill	17,088,000
Income Tax	TWD -8.3M
Investing CF	-384,282,000
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2026-06-30
Ma150	29.1
Ma150ch	-13.59%
Ma20	26.07
Ma20ch	-3.53%
Net CF	-75,768,000
Next Earnings Date	2026-11-09
Open	25.45
Position In Range	25
Ppne	38,627,000
Price Date	2026-09-11
Ptbv Ratio	3.39
Relative Volume	0.89x
Revenue	236,583,000x
SBC By Revenue	3.8x
Share Based Comp	9,000,000
Tax By Revenue	-3.51x
Tr6m	-30.81%
Volume	79,420
Z Score	57.83

TPEX/6733 (TPEX/6733)

Price

Financial snapshot

Fair-value bridge

Latest news · TPEX/6733

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TPEX/6733 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TPEX/6733

Frequently asked questions